The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical Prostatectomy

Launched by UNIVERSITY HOSPITAL OLOMOUC · May 12, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help men with localized prostate cancer prepare for and recover from surgery called radical prostatectomy, which is a common treatment for this type of cancer. The trial focuses on using telemedicine, which means patients will receive support and monitoring through technology like wearable devices and online consultations with physiotherapists. The goal is to improve patients' physical fitness before and after surgery and to reduce the risk of urinary incontinence, a common issue that can affect quality of life after the operation.

To be eligible for this trial, participants need to have a confirmed diagnosis of localized prostate cancer and be scheduled for surgery without having received previous treatments like radiation. They should also be able to exercise and have reliable internet access to use the technology involved in the study. Participants can expect to engage in a structured program that includes exercises and consultations to help them prepare for surgery and recover afterward. Overall, this study is an exciting opportunity to explore how technology can enhance care for prostate cancer patients.

Gender

MALE

Eligibility criteria

• Inclusion criteria:
• • Biopsy-confirmed localized prostate cancer (ICD code C.61).
• • Indicated for radical prostatectomy, with or without pelvic lymphadenectomy (ePLND).
• • Not previously treated for prostate cancer, including radiation therapy to the pelvis, major pelvic surgery, or placement of a penile implant or artificial urinary sphincter.
• • No known urethral stricture or colostomy or chronic urinary catheterization.
• • No medical or current psychiatric disorders that precludes their participation in the study.
• • Status of the musculoskeletal system allowing physical exercise.
• • Urinary continent at baseline.
• • Has reliable internet and the skills/knowledge to use technologies use for the study.
• Exclusion criteria:
• • Other malignant tumors, except for benign skin carcinoma.
• • Active treatment for other oncological diagnoses.
• • Presence of preoperative urinary incontinence.
• • Diagnosed mental or cognitive disorders.
• • Prior pelvic radiotherapy or hormone therapy for prostate cancer recurrence.
• • Severe musculoskeletal disorders preventing active exercise
• • Inability to use required technologies